Literature DB >> 16565831

Molecular and hematological profiles of hemoglobin EE disease with different forms of alpha-thalassemia.

Goonnapa Fucharoen1, Jaruwan Trithipsombat, Suparerk Sirithawee, Supawadee Yamsri, Yossombat Changtrakul, Kanokwan Sanchaisuriya, Supan Fucharoen.   

Abstract

We describe hematologic and DNA characterization of hemoglobin (Hb) E homozygote with various forms of alpha-thalassemia in Thai individuals. Altogether, 131 unrelated adult subjects with Hb EE at routine Hb analysis were studied. Forty-two cases were found to carry alpha-thalassemia with ten different genotypes. These included 21 cases with alpha(+)-thalassemia heterozygote (-alpha(3.7)/alphaalpha), one case with alpha(+)-thalassemia heterozygote (-alpha(4.2)/alphaalpha), six cases with Hb Constant Spring heterozygote (alpha(CS)alpha/alphaalpha), four cases with homozygous alpha(+)-thalassemia (-alpha(3.7)/-alpha(3.7)), one case with homozygous alpha(+)-thalassemia (-alpha(4.2)/-alpha(4.2)), two cases with compound alpha(+)-thalassemia/Hb Constant Spring (-alpha(3.7)/alpha(CS)alpha), one case with compound alpha(+)-thalassemia/Hb Paksé (-alpha(3.7)/alpha(PS)alpha), four cases with alpha(0)-thalassemia heterozygote (--(SEA)/alphaalpha), and, unexpectedly, two cases with compound alpha(0)-thalassemia/alpha(+)-thalassemia [(--(SEA)/-alpha(3.7)) and (--(SEA)/-alpha(4.2))]. The hematological expression of these Hb E homozygotes with various forms of alpha-thalassemia was presented comparatively with those of the 89 cases of pure Hb E homozygotes. Overlapping levels of Hb E, Hb F, and other hematological parameters were observed which did not predict clinical severity, indicating a need for alpha-globin gene analysis for accurate diagnosis and improved genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565831     DOI: 10.1007/s00277-006-0093-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  4 in total

1.  Thalassemia and hemoglobinopathies in an ethnic minority group in Central Vietnam: implications to health burden and relationship between two ethnic minority groups.

Authors:  Nga Thi Nguyen; Kanokwan Sanchaisuriya; Pattara Sanchaisuriya; Hoa Van Nguyen; Hoa Thi Thuy Phan; Goonnapa Fucharoen; Supan Fucharoen
Journal:  J Community Genet       Date:  2017-05-11

2.  Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China.

Authors:  Jing He; Wenhui Song; Jinlong Yang; Sen Lu; Yuan Yuan; Junfu Guo; Jie Zhang; Kai Ye; Fan Yang; Fangfang Long; Zhiyu Peng; Haijing Yu; Le Cheng; Baosheng Zhu
Journal:  Genet Med       Date:  2017-01-26       Impact factor: 8.822

3.  α0-thalassemia in affected fetuses with hemoglobin E-β0-thalassemia disease in a high-risk population in Thailand.

Authors:  Supawadee Yamsri; Simaporn Prommetta; Hataichanok Srivorakun; Wachiraporn Taweenan; Kanokwan Sanchaisuriya; Attawut Chaibunruang; Goonnapa Fucharoen; Supan Fucharoen
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

4.  Hemoglobins F, A2 , and E levels in Laotian children aged 6-23 months with Hb E disorders: Effect of age, sex, and thalassemia types.

Authors:  Benchawan Kingchaiyaphum; Kanokwan Sanchaisuriya; Goonnapa Fucharoen; Attawut Chaibunruang; Sonja Y Hess; Guy-Marino Hinnouho; Maxwell A Barffour; Kimbery R Wessells; Sengchanh Kounnavong; Supan Fucharoen
Journal:  Int J Lab Hematol       Date:  2020-02-12       Impact factor: 2.877

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.